X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (115) 115
middle aged (95) 95
male (94) 94
female (86) 86
aged (84) 84
adult (67) 67
hematology (63) 63
index medicus (55) 55
oncology (52) 52
aged, 80 and over (34) 34
cancer (33) 33
treatment outcome (30) 30
transplantation (25) 25
chemotherapy (22) 22
lymphomas (22) 22
medicine & public health (22) 22
antineoplastic combined chemotherapy protocols - therapeutic use (21) 21
retrospective studies (20) 20
japan (19) 19
leukemia (19) 19
adolescent (18) 18
disease-free survival (18) 18
therapy (18) 18
non-hodgkins-lymphoma (17) 17
prognosis (17) 17
t cells (17) 17
lymphoma (15) 15
rituximab (15) 15
survival (15) 15
expression (13) 13
leukemia/lymphoma (13) 13
survival rate (13) 13
kaplan-meier estimate (12) 12
leukemia-lymphoma, adult t-cell - drug therapy (12) 12
analysis (11) 11
antineoplastic agents - therapeutic use (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
cyclophosphamide (10) 10
hematopoietic stem cells (10) 10
japan - epidemiology (10) 10
leukemia-lymphoma, adult t-cell - mortality (10) 10
recurrence (10) 10
remission induction (10) 10
stem cells (10) 10
young adult (10) 10
antimitotic agents (9) 9
antineoplastic agents (9) 9
immunohistochemistry (9) 9
leukemia-lymphoma (9) 9
lymphoma, b-cell - drug therapy (9) 9
neoplasm staging (9) 9
polymerase chain reaction (9) 9
survival analysis (9) 9
bone-marrow-transplantation (8) 8
immunotherapy (8) 8
leukemia-lymphoma, adult t-cell - pathology (8) 8
lymphoma, large b-cell, diffuse - drug therapy (8) 8
malignant-lymphoma (8) 8
medical colleges (8) 8
pathology (8) 8
research (8) 8
toxicity (8) 8
transplantation, homologous (8) 8
abridged index medicus (7) 7
acute myeloid-leukemia (7) 7
antineoplastic agents - administration & dosage (7) 7
antineoplastic agents - adverse effects (7) 7
bone marrow (7) 7
child, preschool (7) 7
chronic lymphocytic-leukemia (7) 7
drug administration schedule (7) 7
follicular lymphoma (7) 7
hematology, oncology and palliative medicine (7) 7
leukemia-lymphoma, adult t-cell - therapy (7) 7
lymphoma, b-cell - pathology (7) 7
lymphoma, large b-cell, diffuse - mortality (7) 7
non-hodgkin's lymphomas (7) 7
trial (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
base sequence (6) 6
child (6) 6
clinical trials (6) 6
disease progression (6) 6
dose-response relationship, drug (6) 6
follow-up studies (6) 6
gene (6) 6
health aspects (6) 6
hematopoietic stem cell transplantation - methods (6) 6
hemic and lymphatic diseases (6) 6
immune system diseases (6) 6
leukemia, myeloid, acute - genetics (6) 6
leukemia-lymphoma, adult t-cell - immunology (6) 6
low-grade (6) 6
malignant lymphoma (6) 6
molecular sequence data (6) 6
monoclonal-antibody (6) 6
multiple myeloma (6) 6
patients (6) 6
progression-free survival (6) 6
proportional hazards models (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 10/2017, Volume 28, Issue suppl_9
Journal Article
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2014, Volume 25, Issue suppl_5, pp. v35 - v35
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 11, pp. 1157 - 1163
Journal Article
Journal Article
Journal Article
Cancer Science, ISSN 1347-9032, 09/2019, Volume 110, Issue 9, pp. 2924 - 2932
This multicenter, open‐label phase 1/2 study evaluated single‐agent carfilzomib in 50 heavily pretreated Japanese patients with relapsed/refractory multiple... 
clinical trial | hematopoiesis | multiple myeloma | Japanese | carfilzomib | SURVIVAL | DEXAMETHASONE | ONCOLOGY | LENALIDOMIDE | OPEN-LABEL | Carfilzomib | Clinical trials | Relapse | Analysis | Multiple myeloma | Diseases | Leukopenia | Hematology | Neutrophils | FDA approval | Survival | Studies | Chemotherapy | Lymphopenia | Technical communication | Drug dosages | Neutropenia | Pharmaceuticals | Original
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2015, Volume 169, Issue 5, pp. 672 - 682
Summary This multicentre, randomized, phase II study was conducted to examine whether the addition of mogamulizumab, a humanized anti‐CC chemokine receptor 4... 
mogamulizumab | randomized phase II study | CCR4 | adult T‐cell leukaemia‐lymphoma | antibody therapy | Adult T-cell leukaemia-lymphoma | Mogamulizumab | Antibody therapy | Randomized phase II study | adult T-cell leukaemia-lymphoma | MONOCLONAL-ANTIBODY KW-0761 | RECEPTOR | LEUKEMIA/LYMPHOMA | HEMATOLOGY | EXPRESSION | ASSOCIATION | TRANSPLANTATION | Doxorubicin - therapeutic use | Nitrosourea Compounds - adverse effects | Prednisolone - adverse effects | Nitrosourea Compounds - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Carboplatin - adverse effects | Antibodies, Monoclonal, Humanized - administration & dosage | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Carboplatin - therapeutic use | Vindesine - adverse effects | Vindesine - therapeutic use | Aged, 80 and over | Adult | Female | Prednisolone - therapeutic use | Etoposide - adverse effects | Leukemia-Lymphoma, Adult T-Cell - mortality | Etoposide - therapeutic use | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Doxorubicin - adverse effects | Chemotherapy | Lymphomas | T cells | Leukemia | Cancer | Haematological Malignancy | Research Paper
Journal Article
International Journal of Hematology, ISSN 0925-5710, 4/2017, Volume 105, Issue 4, pp. 470 - 477
Journal Article
Journal Article